INTRODUCTION
============

The multinucleated myotubes, which are generated by the fusion of several mononucleated myoblasts during embryonic and fetal developments, are the functional unit of skeletal muscle that generates force by their contraction \[[@b1-ajas-31-3-439]\]. The regeneration of myotubes after damage or injury is considered to be very rapid and gets established within weeks with the help of precursor cells, such as satellite cells or muscle derived stem cells (MDSCs). The skeletal muscle satellite cells are non differentiated quiescent cells, which are known to arise from embryonic mesoderm and locate themselves on the surface of myofibers beneath the basal membrane \[[@b1-ajas-31-3-439]\]. During injury, quiescent satellite cells get activated to proliferate and produce nascent myofibers for the efficient repair \[[@b2-ajas-31-3-439]\]. However, depending on the environmental conditions, satellite cells are also capable of differentiating into certain other cell type like adipocytes, osteocytes, chondrocytes etc. \[[@b3-ajas-31-3-439]\]. Furthermore, marbling in muscle enhances flavor and nutritional value of meats and those appeals to the consumers. Therefore, in the past several researchers have tried to increase marbling with the use of various PPAR-gamma agonists. Thiazolidinediones (TZD's) are one such adipogenic inducer that has been so far used as antidiabetic agents in humans \[[@b4-ajas-31-3-439]\]. Since retinoic acid (RA) has been found to be liposoluble vitamin A (retinol) and its acidic metabolite acts as a ligand for transcription factors of the retinoic acid receptors (RAR; RARα, RARβ, and RARγ) \[[@b5-ajas-31-3-439]\]. Furthermore, it was also shown that RA could serve as a ligand for the nuclear receptor peroxisome proliferation-activated receptor β/δ (PPARβ/δ) \[[@b6-ajas-31-3-439]\] and probably favors binding to PPARβ/γ to induce anti-apoptotic response in higher concentrations of fatty acid binding protein-5 (FABP5) \[[@b6-ajas-31-3-439]\]. We therefore assume and consider TZD's as one the strong agents to initiate and produce FABP5 concentration. However, RA in combination with the TZD's could attain increased levels of adipogenesis as compared to the use of TZD's alone. Furthermore, this combination could bind PPARβ/γ comfortably to initiate a better adipogenic phenomenon. We therefore, designed the study to investigate the similar phenomenon to happen on Korean black goat myogenic satellite cells (GMSC's) involving the lipid and glucose metabolism when the RA and linolenic acid combined with thiozolidienediones.

Due to the paucity of literature on this subject instigated us to investigate the possible adipogenic differentiation of GMSCs and potential insulin sensitization (through the production of smaller lipid droplets) by RA with TZD's.

MATERIALS AND METHODS
=====================

Chemicals, antibodies and primers
---------------------------------

We purchased Dulbecco's modified Eagle's medium (DMEM), penicillin and streptomycin (PS) from Welgene (Dalseogu, Daegu, Korea), fetal bovine serum (FBS) from HyClone Laboratories, Inc (Logan, UT, USA), horse serum (HS) from Gibco Technologies Inc (Grand Island, NY, USA), Power cDNA synthesis kit from Intron biotechnology and primers from Macrogen. The RA, linolenic acid, pigskin gelatin, dexamethasone, insulin, biotin, ascorbic acid, pantothenic acid, ascorbic acid and protease (Pronase \[P5147\]) were obtained from Sigma Aldrich (Seoul, Korea). Xylazine and Ketamine were obtained from Yuhan Co., Seoul, Korea. GMSC's were isolated from 90 days old goats.

Animal rearing and tissue collection
------------------------------------

Eight Korean black goats (approximately 90 days old) were utilized for the experiment and maintained in the animal house meant especially for animal experimentation (having all the relevant facilities required ethically for animal experimentation) of the college of animal life sciences, Kangwon National University, Republic of Korea. All these procedures were carried out as per the ethical guidelines and regulations for animal experimentation of Kangwon National University, Republic of Korea. A total of four goats were fed with high fat rich diet to gain fat generalized body pad relatively faster. The ingredient composition of the concentrate fed to treatment group is given in [Table 1](#t1-ajas-31-3-439){ref-type="table"} together with analyzed chemical composition of the concentrate and hay. The Korean black goats in the control group had access to Timothy hay on an *ad libitum* basis. Goats were dewormed initially with broad-spectrum anthelmintics and were vaccinated against prevalent contagious diseases. The body weight (BW) of individual goats was recorded at the start and thereafter at fortnightly intervals until 90 days of the trial in the morning before feeding, in order to assess changes in BW and average daily gain. The biopsied muscle tissues were first kept in cold phosphate buffered saline (PBS) containing 5% antibiotics, until the isolation of GMSC's. Finally, the surgical opening was closed as per the routine surgical maneuver. Postoperative care and management was done under the supervision of a veterinary surgeon for a period of one week.

Goat myogenic satellite cells isolation
---------------------------------------

GMSC's were isolated from semitendinosus muscle as described the literature \[[@b7-ajas-31-3-439]\] with some modifications. Isolated primary myoblasts were stored in liquid nitrogen until used.

Flow cytometry
--------------

We performed flow cytometric analysis as demonstrated by the literature \[[@b8-ajas-31-3-439]\]. Briefly, to assess expressions of specific markers, we harvested cells using citrate saline buffer (0.134 mol/L KCl, 0.015 mol/L Na citrate), and washed them twice with cold PBS containing 0.002% ethylenediaminetetraacetic acid (EDTA) and 10 mmol/L NaN~3~. The cells fixed with 4% paraformaldehyde were incubated with primary antibodies, which were diluted in 1:50 ratio in PBS containing 0.5% bovine serum albumin (BSA), for 1 h on ice, followed by a wash with PBS-BSA. The non-labelled primary antibodies were visualized by using 1:50 diluted mouse anti-goat immunoglobulins G (secondary antibodies) conjugated to fluorescein-isothiocyanate. After washing, we analyzed cell suspensions using a flow cytometer (Epics XL analyzer; Coulter Corporation, Miami, FL, USA) after the addition of 5 mL of a 1-mg/mL solution of propidium iodide to exclude nonviable cells. We analyzed at least 1×10^4^ cells/sample.

Doubling time
-------------

The isolated primary cells were counted with a hemocytometer by diluting with trypan blue. The same isolated primary cells (1×10^5^) were seeded in a 100 mm dish containing DMEM supplemented with 20% FBS and 1.1% PS for proliferation. The media was changed in 2 to 3 days interval until 80% confluency. At this point, the cells were passaged with the help of 0.25% trypsin and counted to calculate the final number of cells. A certain portion of these cells were again reseeded and carried on till passage 4, subsequently the culturing time was also recorded. The doubling time was calculated according to the literature \[[@b9-ajas-31-3-439]\] with certain modifications. i.e.,
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Where, DT is the cell-doubling time; CT, the cell culture time; CD, the cell-doubling number; N~f~, the final number of cells; N~i~, the initial number of cells.

Cell culture
------------

The isolated GMSC's were characterized, by flow cytometric analysis, and proliferated in DMEM supplemented with 10% FBS and 1.1% PS and incubated at 37°C in 5% CO~2~ incubator. After reaching 70% to 80% confluency, the cells were subcultured with the help of trypsin EDTA. The 2nd passage cells were used for differentiation experiments.

For myogenic differentiation of GMSC's, 1×10^6^ cells were seeded in 60 mm dish and cultured with DMEM containing 2% HS and 1.1% PS. Media were being changed in every 48 hours and samples were taken on days 0, 4, and 8.

For adipogenic differentiation of GMSC's, 1×10^6^ cells were seeded into 60 mm culture dish. After getting 80% confluency, the cells were induced by adipogenic differentiation media comprising, DMEM containing 2% HS, 1.1% PS, 50 μM ascorbic acid, 33 μM biotin, 10 μM acetic acid, 17 μM pantothenic acid, 0.5 μM 3-Isobutyl-1-methylxanthine, 1 μM dexamethasone, 10 μM insulin, 10 μM 2, 4-TZD. In addition, 2 dishes were treated with 100 mM LA and 2 with 1 nM RA. Media were changed in every 48 hours with respective concentrations of TZD, LA, and RA in appropriate dishes till the final day of induction. Samples were harvested for RNA isolation on days 0, 4, and 8. Staining samples were washed with PBS and fixed with 4% paraformaldehyde for oil red O (ORO) staining.

Fusion index
------------

The myogenic differentiated cells were collected on 0, 4, and 8 days of culture. The collected samples were stained with hematoxyline (Sigma Aldrich, Korea) nuclei staining dye and scored the total number of nuclei as well as the number of nuclei incorporated with the myotubes within 10 different microscopic fields (400× magnification). The myoblasts containing at least 3 nuclei are counted as myotubes, further the fusion index for each sample was calculated as the percentage of nuclei incorporated to the myotubes compared to the total number of nuclei scored over the particular microscopic field \[[@b4-ajas-31-3-439]\].

Adipocyte stain uptake and oil red O staining
---------------------------------------------

Measurement of stain retained by the adipoblasts was done to determine the increase in the number or size of the adipoblasts. The ORO staining was performed to confirm the adipogenic differentiation of GMSC's. The working stain solution was prepared by diluting 6 parts of stock stain solution (0.5% ORO in isopropanol) in 4 parts of deionized wzater. We followed the protocol of Singh et al \[[@b4-ajas-31-3-439]\] with some modifications. Briefly, the formalin fixed cell samples were treated with stain for 10 min. The excess stain was removed, washed with DW and dried before capturing the stained cells under a light microscope. Finally the stain was eluted using 100% isopropanol and its optical density was measured at 500 nm by setting 100% isopropanol as blank \[[@b10-ajas-31-3-439]\].

Reverse-transcriptase polymerase chain reaction
-----------------------------------------------

Total RNA was isolated from each sample using TRIZOL reagent according to the standard protocols. Total RNA (8 μg) was taken to synthesis cDNA using the power cDNA synthesis kit according to the manufacturer's instructions. So synthesized cDNA was used as template in polymerase chain reaction (PCR), which was performed with Takara PCR kit on the specific primer conditions (initial denaturation at 95°C for 5 minutes, followed by 35 cycles of 95°C for 40 s, amplification temperature (Temp, [Table 2](#t2-ajas-31-3-439){ref-type="table"}) for 1 min, 72°C for 40 s and a final elongation at 72°C for 8 min). Amplified templates were resolved in 1% to 1.2% agarose gel stained with Ethidium bromide and visualized under UV gel documentation system.

Statistical analysis
--------------------

The treatments at different time intervals were analyzed by analysis of variance, using the statistical software package SAS (SAS Inst. Inc., Cary, NC, USA). The significant differences were determined (p\<0.05, p\<0.01) by the Duncan's multiple range tests using SAS.

RESULTS
=======

Cytofluorimetric analysis of purified GMSC's and it proliferative property
--------------------------------------------------------------------------

After purification by differential trypsinization and adherence, we further cultured cells until passage 2. We harvested passage 2 cells and analyzed them by flow cytometry to evaluate stemness-related CD markers, and to verify whether these cells were able to maintain the characteristics of stemness. As shown in [Figure 1A](#f1-ajas-31-3-439){ref-type="fig"}, at passage 2, purified GMSC's expressed significant levels of CD106 and CD44 (p\<0.01) (stemness factors) and CD13 and CD34 (p\<0.05) (specific markers for satellite cells). α-Smooth muscle actin (α-SMA) and vimentin was also observed to significant relatively. The results shown represent three independent experiments.

Cellular morphology of purified GMSC's and theirdoubling time during proliferation
----------------------------------------------------------------------------------

Purified GMSC's appeared as tiny and small round spheres initially when seeded, but later it adhered strongly to the dish surface. However, more than 95% adherence was apparent only after 24 hours. From day 2 onwards the cells stretched to give fusiform appearance. Cellular extension called filapodia's helped each cell to elongate and adhere to the culture plates and probably provided enough strength to proliferate and divide. The process of proliferation continued, and cells assumed spindle shape with elongated nucleus. All the cells had a distinct nucleus, sometimes with nucleolus and abundant cytoplasm. The viability of cells at every stage of proliferation was \>95%. We dislodged the cellular colonies once we realized that the cells have reached a stage of contact inhibition and further distributed equally to expand them further. After the first passage the cells assumed a faster growth relatively and assumed fusiform-like morphology and showed 90% to 95% confluent state within 2 to 3 d ([Figure 2A](#f2-ajas-31-3-439){ref-type="fig"}). The isolated myoblast cells were initially round in shape in suspending media, however it became spindle as soon as it got attached to the bottom of the dish. The attached cells grew rapidly and were passaged upon attaining \>95% confluent stage. The doubling time was calculated while subculturing and it showed increased mitotic time with each passage. Finally, for differential experiments we took second passage cells.

Determination of myogenic lineage differentiation of purified GMSC's
--------------------------------------------------------------------

GMSC's formed complete multi-nucleated myofiber morphology when cultured under limited serum conditions (2% HS). The myotube formation initiated since the fourth day ([Figure 2A](#f2-ajas-31-3-439){ref-type="fig"}) of culturing with limited serum, and on further days, the length of the myotubes increased gradually. From the fusion index data ([Figure 2C](#f2-ajas-31-3-439){ref-type="fig"}), it is clear that the nuclei count in the myotube was increasing significantly (p\<0.05) according to the time, since day 4. On reverse-transcriptase polymerase chain reaction (RT-PCR), the myogenic marker genes such as myogenic differentiation (MyoD), αSMA, and myosin heavy chain (MHC) showed different expressions on different time periods. The MyoD expression was not detected much within these periods, however, a slight increase in its expression was noted on 4th day. The contractile gene, αSMA had a higher expression in the initial days, however, it declined rapidly on the 4th day and increased a bit on the 8th day samples. Further, the expression of MHC was detected lesser on the 4th day, however its maximum expression (p\<0.01) was detected on the 8th day of the experiment ([Figure 2B](#f2-ajas-31-3-439){ref-type="fig"}).

Determination of thiazolidenediones (PPAR-gamma ligand) adipogenic potentialon purified GMSC's alone and in combination with either retinoic acid orlinolenic acid
------------------------------------------------------------------------------------------------------------------------------------------------------------------

The preconfluent cells, when treated withwith TZD, LA+TZD, and RA+TZD did not formnot form myotubes. Rather, they intended to acquire ring shaped morphology with increased synthesis and accumulation of triglycerides ([Figure 3A](#f3-ajas-31-3-439){ref-type="fig"}). The triglyceride accumulation within the cells was detected by ORO staining ([Figure 3A](#f3-ajas-31-3-439){ref-type="fig"}) and elution index was found to be significant (p\<0.01) in LA+TZD compared to TZD and RA+ TZD treated cells ([Figure 3B](#f3-ajas-31-3-439){ref-type="fig"}). Data obtained further supported the results obtained by RT-PCR ([Figure 4](#f4-ajas-31-3-439){ref-type="fig"}). Adipose specific genes such as PPARγ, adiponectin (Adipo Q), and lipoprotein lipase (LPL) have shown progressive expressions upon incubation, however, highest expressions (p\<0.01) in LA+TZD treated cells than TZD and RA+TZD were noted. Similarly, the terminal adipogenic differentiation marker CCAAT/enhancer binding protein α (C/EBPα) was found to be highly expressed (p\<0.01) in the LA+TZD as compared to TZD alone and RA+TZD treatments.

DISCUSSION
==========

CD34, a cluster of differentiation gets activated through the alternative splicing just before the end of transcription and has been demonstrated to regulate differentiation and lineage primed progenitor compartments in skeletal muscle cells and has been associated with vascular stem cells \[[@b11-ajas-31-3-439]\] as well. GMSC's had significant (p\<0.01) expression levels of CD34, we believe that these GMSC's possess intense immune related components as CD34 has been shown to help T cells to enter lymph nodes \[[@b12-ajas-31-3-439]\]. It further provides us an inkling that the many issues that haunt us and remain unaddressed about the role of mammary epithelium in regulating immune responses (in handling T-cell related queries) during trauma and injury would probably be unfurled provided further investigation are done in this direction. Moreover, due to fact that muscles posses plentiful of common factors with mammary epithelial and myoepithelial stem cells and therefore we believe that these cells could also pave a way to search regenerative possibilities of mammary epithelium and myoepithelium with muscle cells \[[@b13-ajas-31-3-439]\].

CD13 is one of the pluripotency associated markers whose expression in the stem cells helps to retain the differentiation capacity even after indefinite proliferation. Besides its expression has also been reported in mouse multipotent adult progenitor cells and MDSCs \[[@b14-ajas-31-3-439]\]. However, its major function is to regulate the cell motility and chemotaxis. In addition, CD 106 or vascular adhesion molecule-1 (VCAM-1) are also potential markers of quiescent cells \[[@b15-ajas-31-3-439]\]. These adhesion molecules may function in the adhesion of the satellite cells to the basal lamina of the myofibre and participate in the migration of satellite cells in response to different stimuli. The VCAM is expressed in both myofibres and satellite cells, where as it is limited to satellite cells in adult muscle and it mediates interaction of satellite cells to leukocytes following injury \[[@b15-ajas-31-3-439]\]. Further, GMSC's found to be expressing vimentin gene relatively to a lesser extent, as vimentin is an intermediate filament expressed in mesenchymal cells, which governs the structural maintenance of the cells \[[@b16-ajas-31-3-439]\]. Moreover, vimentin expression was reported in myoblasts and has been associated with regeneration and during muscular repair and that shows that its on and off expressions are event related and has strongly something to do with the regeneration and repair phenomenon \[[@b17-ajas-31-3-439]\].

The cells of control group, however, did not deviate to any other lineage than myogenic lineage when cultured solely in DMEM containing 2% HS revealed that GMSC's would only alter its lineage when strong factors would come forward to upregulate alternate lineage gene markers. The expressions of myogenic specific genes like MyoD, αSMA, and MHC were detected during proliferation and differentiation. MyoD is a member of myogenic regulatory factor, which is one of the initially expressed markers in myogenesis and also has a role to play in the activation of satellite cells \[[@b18-ajas-31-3-439]\] in the event of injury and thereby initiates the process of repair and regeneration. Moreover, it induces the initial differentiation of myoblasts as it has been shown and demonstrated earlier that it is quite capable in relocating chromatin in the lineage restricted loci \[[@b19-ajas-31-3-439]\]. We also witnessed and observed that MyoD expression were strong during the initial stages of differentiation. However, we observed its declining expressions in the formed myotubes.

Similarly the αSMA, which is a vascular isoform of smooth muscle actin, plays an important role in the satellite cell differentiation, were also evident throughout the period of proliferation and differentiation showed the integrity of GMSC's, as αSMA represents that their mere presence in some cellular content relates it to the existence of contractile protein necessary for contraction \[[@b20-ajas-31-3-439]\]. And its associated with the GMSC's apparently reveals that these cells descendents of myogenic lineage and of course are adult and differentiated cells. Moreover, αSMA was noticed dominantly only while the myoblast differentiation and a little expression was detected after the formation contractile myotubes \[[@b21-ajas-31-3-439]\] in the primary mouse myoblasts. On the other hand, we observed significantly (p\<0.01) upregulated MHC expressions in the GMSC's during differentiation in GMSC's. MHC is a thick filament component and a predominant protein in skeletal muscle, which is related to contraction \[[@b22-ajas-31-3-439]\] shows that the MHC components starts developing and concentrating and gets clearly and strongly expressed only while myoblast starts turning into myotubes as well as in the fully differentiated myotubes \[[@b23-ajas-31-3-439]\].

The RA is derived from the liposoluble vitamin A (retinol). Molecular basis of vitamin A action was elucidated almost three decades back and was demonstrated that its acidic metabolite, RA, acts as a ligand for transcription factors of the RAR nuclear receptor superfamily and claimed RA as a potent transcriptional activator than repressor. All trans-retinoic acid have been demonstrated to regulate gene expression and all vitamin A metabolite (RA) regulates gene expression by activating specific members of the superfamily of transcription factors known as nuclear hormone receptors. It has long been established that many biological activities of RA are mediated by RAR (RARα, RARβ, and RARγ) \[[@b5-ajas-31-3-439]\]. However, recently it was shown that in addition to activating RARs, RA can also serve as a ligand for the nuclear receptor PPARβ/δ \[[@b6-ajas-31-3-439]\]. However, it has been also observed that retinoic acid favours binding to PPARβ/γ, which in turn can induce anti-apoptotic and proliferative responses only when FABP5 concentration becomes higher \[[@b6-ajas-31-3-439]\]. We therefore, assume and consider TZD's as one the strong agents to initiate and produce FABP5 concentration and because we observed that when we used RA in combination with the TZD's, level of adipogenesis increased significantly as compared to the use of TZD's alone. RA in combination with TZD's has probably become the right choice of combination for binding with PPARβ/γ comfortably to initiate a better adipogenic phenomenon. We, therefore, report that as the repertoire of direct targets for PPARβ/δ includes genes involved in lipid and glucose metabolism, and that activation of this receptor increases lipid catabolism in skeletal muscle and adipose tissue and therefore prevents the development of obesity and improves insulin sensitivity in obesity \[[@b24-ajas-31-3-439]\]. Consequently, we propose PPARβ/δ agonists may be efficacious agents in the treatment of the metabolic syndrome and it has also been observed earlier that RA functions as a PPARβ/δ ligand, which raises the intriguing possibility of its salient roles in the regulation of sugar and lipid metabolism and disposition \[[@b25-ajas-31-3-439]\].

As far as TZD's pharmacological actions are concerned, TZD's alter PPARγ expression to reduce insulin resistance through adipogenic differentiation of myoblasts. It has been demonstrated that in the absence of increased energy storage, TZD's would be expected to produce more fat cells of a smaller average size, which are usually more sensitive to insulin. Such a response in GMSC's would be expected to produce greater insulin-dependent glucose uptake \[[@b26-ajas-31-3-439]\]. Moreover, as insulin is a powerful antilipolytic agent, smaller fat cells with increased insulin sensitivity would be expected to have relatively lower rates of lipolysis, because high levels of free fatty acids may be causally involved in the induction of insulin resistance, this could affect insulin sensitivity at distant sites such as muscle and liver \[[@b27-ajas-31-3-439]\]. This mechanism would also be compatible with the so-called randle effect, where the tendency of muscle to utilize glucose as an energy source is inversely correlated with the use of fatty acids as an energy source. There are also reports that TZD administration to rodents greatly increases the amounts of brown adipose tissue \[[@b28-ajas-31-3-439]\]. Considering that this tissue functions to dissipate energy through the oxidation of fatty acids, it could also reduce circulating lipid levels and have a beneficial effect on insulin sensitivity.

Moreover, the TZD's and its subfamily, though are PPAR-gamma stimulators but normally does not work as other ligands that have more full agonist activity on PPARγ/retinoic X receptor (RXR) heterodimers. Therefore, TZD's usage in combination with RA holds validity, as trxhere are reports that RXR agonists could have antidiabetic action in obese/diabetic rodents carries exciting promise \[[@b29-ajas-31-3-439]\]. These drugs working together with a PPAR-ligand could theoretically lower glucose more than either one alone. However, it is not clear from the studies done to date whether maximal costimulation of this heterodimeric receptor pair gives a larger glucose-lowering effect than does maximal stimulation of PPAR alone.

α-Linolenic acid enhances adipogenic differentiation
----------------------------------------------------

The LA, the n-3 or omega-3 polyunsaturated fatty acid is an essential poly unsaturated fatty acid, having potential medicinal applications. We reported earlier that LA stimulates adipocyte differentiation with ease in preadipocytes through acute induction in PPARγ, C/EBPα, and LPL mRNA expressions \[[@b13-ajas-31-3-439]\]. Accordingly, in the present experiment, enhanced expression of PPARγ was detected in all the three induction medium consisting of TZD. Although, the significant (p\<0.01) upregulation in LA+TZD treatment showed than the other two treatments, which suggests the combination of LA along with TZD empowered the activation of PPARγ than the treatment with TZD alone. The expressions of adipocyte specific marker genes like PPARγ, Adipo Q, LPL, and C/EBPα were analyzed and quantified by different methods to confirm the accountability of conversion of GMSC's.

PPARγ, a member of PPARs that belongs to the nuclear hormone receptor superfamily, is abundantly expressed in all types of adipose tissue and its expression is sufficient enough for the initiation of adipogenesis \[[@b30-ajas-31-3-439]\]. TZD's produces adipogenic induction efficiently and could be appreciated for its function as a strong activator of PPARγ \[[@b31-ajas-31-3-439]\]. Besides, Adipo Q, a secretory protein synthesized in the adipose tissue, plays a vital role in the lipids and carbohydrate metabolisms in muscle tissue by enhancing insulin sensitivity and fatty acid oxidation. Moreover, it is a vital element that reduces the expressions of gluconeogenic factors \[[@b32-ajas-31-3-439]\], thereby its declined expression in obesity or diabetic conditions is observed in humans, though it is predominantly expressed during the adipocyte differentiation \[[@b33-ajas-31-3-439]\]. However, our findings relate to the observation of the literature \[[@b33-ajas-31-3-439]\], where, higher expression of AdipoQ augmented the increased lipid accumulation in GMSC's ([Figure 3A](#f3-ajas-31-3-439){ref-type="fig"}) during adipogenic differentiation.

*LPL* gene was detected highly expressed throughout the adipocyte differentiation in our experiments, where LPL is an enzyme which regulates the fatty acid deposition and its metabolism in adipose tissue. The circulating triglycerides will be hydrolyzed by LPL and the fatty acids, which got released from this process will be taken up and stored in the adipose tissue \[[@b34-ajas-31-3-439]\]. In addition, LPL is an early marker for adipocyte differentiation, which is expressed independently of any inducers, suggesting that LPL expression blocks the cell proliferation and initiates adipocyte differentiation upon confluency \[[@b35-ajas-31-3-439]\]. Furthermore, the CCAAT/enhancer binding proteins (C/EBPs) are some of the first transcription factors found to be involved in the adipogenesis. The members of this family like C/EBPα, C/EBPβ, and C/EBPδ along with PPARγ can induce the adipogenesis even in non-adipogenic cells \[[@b36-ajas-31-3-439]\] through a "feed-forward" fashion. As in our results, upregulated expression of C/EBPα was observed in the final days of LA+TZD treatment, suggests terminal adipogenic differentiation. PPARγ and C/EBPα will be highly expressed for the rest of the differentiation process and throughout the life of mature adipocytes \[[@b37-ajas-31-3-439]\]. Consequently, the joined expressions of all these genes, particularly PPARγ and C/EBPα after the adipogenic inductions are sufficient enough to block the myogenic fate and to initiate the adipogenic differentiation in myosatellite cells \[[@b4-ajas-31-3-439]\]. Whereas the control myogenic samples, which was maintained without induction did not exhibit the adipogenic gene expressions, besides it retained the myogenic fate and formed myofibers, *in vitro*.

Moreover, the variations in the adipose specific gene expressions were visible according to the treatments. Where, the first treatment group was induced with TZD, which is a well known ligand for PPARγ receptor and found to be an effective inducer for adipocyte differentiation, *in vitro* \[[@b4-ajas-31-3-439],[@b38-ajas-31-3-439]\]. Though in our study, its individual effect on adipogenic stimulation found to be less compared to the combined effect of TZD along with RA and LA. Interestingly, the combined TZD+RA treatment found upregulating the adipose specific genes, though the previous reports state RA as a potential adipogenic inhibitor \[[@b39-ajas-31-3-439]\]. Moreover, the study of the literature \[[@b38-ajas-31-3-439]\] used the similar combination, that is TZD+RA, and found RA suppressed the TZD mediated adipogenesis. In contrast to these findings, our result showed that the RA along with TZD does not inhibit but stimulates the expressions of adipose specific genes, and found to produce smaller adipocytes when compared to the LA in combination with TZD's.

CONCLUSION
==========

Higher levels of free fatty acids cause enhanced insulin resistance in muscle and liver, however, its regulation through drugs like TZD's showed improved insulin sensitivity. Nevertheless, TZD's promotes PPARγ mediated adipocyte conversion in myoblasts. Our combined treatments of TZD's together with RA or LA showed significant fat cell transition of Korean black goat myosatellite cells though, the RA combination produced, comparatively, enormous amount of insulin sensitive smaller preadipocytes, whereas LA combination found to be producing fully differentiated large adipocytes, which are insulin resistant. Thus, we suggest that the RA in combination with TZD's may provide improved insulin sensitization in diabetic conditions as future approach in therapeutics.
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![Characterization of isolated myosatellite cells. Characterization of primary capra myosatellite cells using the stem cell as well as myoblast specific markers such as cluster of differentiation 13 (CD 13), CD34, CD44, CD106 and vimentin by flow cytometry (A) and reverse-transcriptase polymerase chain reaction (B). Significant expressions of CD34, CD44, and CD 106 were detected in the myoblast cells (\* p\<0.05, \*\* p\<0.01). (C) The graph shows the changes in doubling time and percentage proliferation rate of isolated capra myoblasts at each passage.](ajas-31-3-439f1){#f1-ajas-31-3-439}

![Morphological changes and fusion index during myogenic differentiation. (A) the morphological changes observed under light microscope in the myogenic control myosatellite cells cultured under limited serum conditions during 0, 2, 4, and 8 days, where, arrows show the myotube formation. (B) Relative expressions of myogenic genes detected through reverse-transcriptase polymerase chain reaction. The bands attained were analyzed using ImageJ, and normalized to the internal loading control GAPDH. (\*\* p\<0.01). (C) The chart shows the fusion index (nuclei count in a single myotube) during the 0, 2, 4, and 8th days of myogenic differentiation. GAPDH, glyceraldehyde-3-phosphate-dehydrogenase.](ajas-31-3-439f2){#f2-ajas-31-3-439}

![Microphotographic view, ORO staining and elution index of differentiating myoblasts. I: Microscopic (A, C, E) and ORO (B, D, F) stained images of myosatellite cells under adipogenic inductions (Day 8). Morphological changes and stained lipid droplets were visible in TZD (A, B), RA+TZD (C, D) and LA+TZD (E, F) induced myoblast cells, under inverted light microscope. II: The differentiating myoblasts were stained with ORO for evaluating the lipid droplet accumulation. Elution indexes of each treatment were quantified by calculating optical density of the isopropanol eluted stain. Whereas, most significant staining was detected under TZD+LA treatment. (\* p\<0.05, \*\* p\<0.01). ORO staining, oil red O staining; TZD, thiazolidinediones.](ajas-31-3-439f3){#f3-ajas-31-3-439}

![Genetic expression analyses of adipose induced myoblast cells. The graphs show the relative expressions of PPARγ (A), Adipo Q (B), LPL (C) and C/EBPα (D) in myoblasts, respectively in 0, 4, and 8 days under TZD, RA+TZD and LA+TZD treatments. Highly significant expressions of adipocyte genes were observed under TZD+LA treatment compared to the other two. Moreover, predominant expression of terminal adipocyte differentiation marker (C/EBPα) was monitored under this treatment. Bands of each reverse-transcriptase polymerase chain reaction product were analyzed and normalized to internal loading control GAPDH using ImageJ software. (\*: p\<0.05, \*\*: p\<0.01). PPARγ, peroxisome proliferation-activated receptor γ; Adipo Q, adiponectin; LPL, lipoprotein lipase; C/EBPα, CCAAT/enhancer binding protein α; TZD, thiazolidinediones, GAPDH, glyceraldehyde-3-phosphate-dehydrogenase.](ajas-31-3-439f4){#f4-ajas-31-3-439}

###### 

Ingredients and analyzed chemical composition of concentrate and Timothy hay

  Sl. No.   Composition     Concentrate   Timothy hay
  --------- --------------- ------------- -------------
  1\.       Dry matter      881           931
  2\.       Crude protein   166           93
  3\.       Ether extract   45            20
  4\.       NDF             343           664
  5\.       ADF             123           418
  6\.       Ash             95            107
  7\.       Ca              12            2
  8\.       P               5             2

NDF, neutral detergent fiber; ADF, acid detergent fiber.

###### 

Primer details used in reverse-transcriptase polymerase chain reaction

  Gene        Accession No.   Sequences                                                         Temp (°C)
  ----------- --------------- ------------------------------- --------------------------------- -----------
  *Adipo Q*   BC140488        5′ GATCCAGGTCTTGTTGGTCCTAA 3′   5′ GAGCGGTATACATAGGCACTTTCTC 3′   60
  *LPL*       M16966          5′ TACCCTGCCTGAAGTTTCCAC 3′     5′ CCCAGTTTCAGCCAGACTTTC 3′       60
  *C/EBPα*    BC149006. 1     5′ AGTCCGTGGACAAGAACAGC 3′      5′ GGTCATTGTCACTGGTCAGC 3′        53
  *PPARγ*     NM001100921.1   5′ ACGGGAAAGACGACAGACAAA 3′     5′ GACGGAGCGAAACTGACACC 3′        59
  *MHC*       NM 017240       5′ AGAAGGAGCAGGACACCAGC 3′      5′ GGTCTCAGGGCTTCACAGGC 3′        57
  *MyoD*      NM 010866. 2    5′ GACAGGGAGGAGGGGTAGAG 3′      5′ TGCTGTCTCAAAGGAGCAGA 3′        59
  *αSMA*      BC158550.1      5′ GATCACCATCGGGAATGAACGC 3′    5′ CTTAGAAGCATTTGCGGTGGAC 3′      60

*Adipo Q*, adiponectin; *LPL*, lipoprotein lipase; *C/EBPα*, CCAAT/enhancer binding protein α; *PPARγ*, peroxisome proliferation-activated receptor γ; *MHC*, myosin heavy chain; *MyoD*, myogenic differentiation; *αSMA*, α-smooth muscle actin.

[^1]: These two authorscontribute equally to this work.
